Z-1905-2021 Class II Terminated

Recalled by Beckman Coulter Inc. — Brea, CA

FDA device recall Z-1905-2021 was initiated by Beckman Coulter Inc. on May 7, 2021 and is designated Class II. Reason for recall: SARS-CoV-2 lgG II numerical results may potentially be multiplied by a factor of 1000 on systems running with assay protocol file (APF) and access assay file (AAF) versions resulting in falsely elev… The recall status is terminated (terminated March 27, 2023). Affected quantity: 13,337 units.

Recall Details

Product Type
Devices
Report Date
June 30, 2021
Initiation Date
May 7, 2021
Termination Date
March 27, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,337 units

Product Description

Access SARS CoV-2 lgG II Reagent, REF: C69057, IVD CE UDI: (01)15099590742744

Reason for Recall

SARS-CoV-2 lgG II numerical results may potentially be multiplied by a factor of 1000 on systems running with assay protocol file (APF) and access assay file (AAF) versions resulting in falsely elevated numerical values.

Distribution Pattern

US: Alabama, Alaska, Arizona, Arkansas, California, Florida, Georgia, Illinois, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, New Hampshire, New Jersey, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, Puerto Rico, Tennessee, Texas, Virginia, West Virginia, Wisconsin, Wyoming, OUS: Andorra, Austria, Croatia, Czech Republic, France, Germany, Gibraltar, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Jordan, Poland, Portugal, San Marino, Slovakia, Slovenia, Spain, United Arab Emirates

Code Information

All Lots